Envoy Medical, Inc.(COCH)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Envoy Medical, Inc. (COCH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores COCH at 6.6/100 on a 32-signal composite quality model, placing it at rank #2,950 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Envoy Medical, Inc. reports quarterly revenue of $51.0K, net income of $-6.0M. Top institutional holders of COCH by reported 13-F value include Nantahala Capital Management, Bleichroeder, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. COCH trades on the Nasdaq exchange and files with the SEC under CIK 1840877. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate COCH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Envoy Medical, Inc. directly from SEC EDGAR.